Literature DB >> 24357674

Cubilin maintains blood levels of HDL and albumin.

Obaidullah Aseem1, Brian T Smith1, Marion A Cooley1, Brent A Wilkerson1, Kelley M Argraves1, Alan T Remaley2, W Scott Argraves3.   

Abstract

Cubilin is an endocytic receptor highly expressed in renal proximal tubules, where it mediates uptake of albumin and filtered forms of apoA-I/HDL. Cubilin deficiency leads to urinary loss of albumin and apoA-I; however, the consequences of cubilin loss on the homeostasis of blood albumin and apoA-I/HDL have not been studied. Using mice heterozygous for cubilin gene deletion (cubilin HT mice), we show that cubilin haploinsufficiency leads to reduced renal proximal tubular uptake of albumin and apoA-I and significantly increased urinary loss of albumin and apoA-I. Moreover, cubilin HT mice displayed significantly decreased blood levels of albumin, apoA-I, and HDL. The levels of albumin and apoA-I protein or mRNA expressed in the liver, kidney, or intestine of cubilin HT mice did not change significantly. The clearance rate of small HDL3 particles (density>1.13 g/ml) from the blood increased significantly in cubilin HT mice. In contrast, the rate of clearance of larger HDL2 particles from the blood did not change significantly, indicating a decreased half-life for HDL particles capable of filtering through the glomerulus. On the basis of these findings, we conclude that cubilin deficiency reduces renal salvage and delivery back to the blood of albumin and apoA-I, which decreases blood levels of albumin and apoA-I/HDL. These findings raise the possibility that therapeutic increase of renal cubilin expression might reduce proteinuria and increase blood levels of albumin and HDL.
Copyright © 2014 by the American Society of Nephrology.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24357674      PMCID: PMC4005305          DOI: 10.1681/ASN.2013060671

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  50 in total

1.  Transcytosis of retinol-binding protein across renal proximal tubule cells after megalin (gp 330)-mediated endocytosis.

Authors:  Michele Marinó; David Andrews; Dennis Brown; Robert T McCLUSKEY
Journal:  J Am Soc Nephrol       Date:  2001-04       Impact factor: 10.121

2.  A patient with cubilin deficiency.

Authors:  Tina Storm; Francesco Emma; Pierre J Verroust; Jens Michael Hertz; Rikke Nielsen; Erik I Christensen
Journal:  N Engl J Med       Date:  2011-01-06       Impact factor: 91.245

3.  Role of megalin (gp330) in transcytosis of thyroglobulin by thyroid cells. A novel function in the control of thyroid hormone release.

Authors:  M Marinò; G Zheng; L Chiovato; A Pinchera; D Brown; D Andrews; R T McCluskey
Journal:  J Biol Chem       Date:  2000-03-10       Impact factor: 5.157

4.  The normal kidney filters nephrotic levels of albumin retrieved by proximal tubule cells: retrieval is disrupted in nephrotic states.

Authors:  L M Russo; R M Sandoval; M McKee; T M Osicka; A B Collins; D Brown; B A Molitoris; W D Comper
Journal:  Kidney Int       Date:  2007-01-17       Impact factor: 10.612

Review 5.  Receptor-mediated endocytosis in renal proximal tubule.

Authors:  Erik Ilsø Christensen; Pierre J Verroust; Rikke Nielsen
Journal:  Pflugers Arch       Date:  2009-06-05       Impact factor: 3.657

6.  Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: The Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  A R Sharrett; C M Ballantyne; S A Coady; G Heiss; P D Sorlie; D Catellier; W Patsch
Journal:  Circulation       Date:  2001-09-04       Impact factor: 29.690

7.  The intrinsic factor-vitamin B12 receptor, cubilin, is a high-affinity apolipoprotein A-I receptor facilitating endocytosis of high-density lipoprotein.

Authors:  R Kozyraki; J Fyfe; M Kristiansen; C Gerdes; C Jacobsen; S Cui; E I Christensen; M Aminoff; A de la Chapelle; R Krahe; P J Verroust; S K Moestrup
Journal:  Nat Med       Date:  1999-06       Impact factor: 53.440

8.  High density lipoprotein-associated sphingosine 1-phosphate promotes endothelial barrier function.

Authors:  Kelley M Argraves; Patrick J Gazzolo; Eric M Groh; Brent A Wilkerson; Bryan S Matsuura; Waleed O Twal; Samar M Hammad; W Scott Argraves
Journal:  J Biol Chem       Date:  2008-07-07       Impact factor: 5.157

9.  Low-density lipoprotein clearance in patients with chronic renal failure.

Authors:  Helena Kastarinen; Sohvi Hörkkö; Heikki Kauma; Anna Karjalainen; Markku J Savolainen; Y Antero Kesäniemi
Journal:  Nephrol Dial Transplant       Date:  2009-02-05       Impact factor: 5.992

10.  Targeted disruption of cubilin reveals essential developmental roles in the structure and function of endoderm and in somite formation.

Authors:  Brian T Smith; Jason C Mussell; Paul A Fleming; Jeremy L Barth; Demetri D Spyropoulos; Marion A Cooley; Christopher J Drake; W Scott Argraves
Journal:  BMC Dev Biol       Date:  2006-06-20       Impact factor: 1.978

View more
  24 in total

1.  How complicated can it be? The link between APOL1 risk variants and lipoprotein heterogeneity in kidney and cardiovascular diseases.

Authors:  Chien-An A Hu; Patricio E Ray
Journal:  Nephrol Dial Transplant       Date:  2015-10-03       Impact factor: 5.992

2.  Urinary apolipoprotein AI in children with kidney disease.

Authors:  Amanda J Clark; Kathy Jabs; Tracy E Hunley; Deborah P Jones; Rene G VanDeVoorde; Carl Anderson; Liping Du; Jianyong Zhong; Agnes B Fogo; Haichun Yang; Valentina Kon
Journal:  Pediatr Nephrol       Date:  2019-06-23       Impact factor: 3.714

3.  Apolipoprotein M modulates erythrocyte efflux and tubular reabsorption of sphingosine-1-phosphate.

Authors:  Iryna Sutter; Rebekka Park; Alaa Othman; Lucia Rohrer; Thorsten Hornemann; Markus Stoffel; Olivier Devuyst; Arnold von Eckardstein
Journal:  J Lipid Res       Date:  2014-06-20       Impact factor: 5.922

Review 4.  Residual Cardiovascular Risk in Chronic Kidney Disease: Role of High-density Lipoprotein.

Authors:  Valentina Kon; Haichun Yang; Sergio Fazio
Journal:  Arch Med Res       Date:  2015-05-23       Impact factor: 2.235

Review 5.  High-density lipoprotein metabolism, composition, function, and deficiency.

Authors:  Ernst J Schaefer; Pimjai Anthanont; Bela F Asztalos
Journal:  Curr Opin Lipidol       Date:  2014-06       Impact factor: 4.776

Review 6.  Kidneys: key modulators of high-density lipoprotein levels and function.

Authors:  Haichun Yang; Agnes B Fogo; Valentina Kon
Journal:  Curr Opin Nephrol Hypertens       Date:  2016-05       Impact factor: 2.894

Review 7.  Kidney as modulator and target of "good/bad" HDL.

Authors:  Jianyong Zhong; Haichun Yang; Valentina Kon
Journal:  Pediatr Nephrol       Date:  2018-10-05       Impact factor: 3.714

8.  Mechanism of how carbamylation reduces albumin binding to FcRn contributing to increased vascular clearance.

Authors:  Shiv Pratap S Yadav; Ruben M Sandoval; Jingfu Zhao; Yifan Huang; Exing Wang; Sudhanshu Kumar; Silvia B Campos-Bilderback; George Rhodes; Yehia Mechref; Bruce A Molitoris; Mark C Wagner
Journal:  Am J Physiol Renal Physiol       Date:  2020-12-07

9.  HDL cholesterol is associated with PBMC expression of genes involved in HDL metabolism and atherogenesis.

Authors:  Liudmila V Dergunova; Elena V Nosova; Veronika G Dmitrieva; Alexandra V Rozhkova; Ekaterina V Bazaeva; Svetlana A Limborska; Alexander D Dergunov
Journal:  J Med Biochem       Date:  2020-09-02       Impact factor: 3.402

10.  Apolipoprotein A-I in mouse cerebrospinal fluid derives from the liver and intestine via plasma high-density lipoproteins assembled by ABCA1 and LCAT.

Authors:  Maki Tsujita; Boris Vaisman; Liu Chengyu; Kasey C Vickers; Kei-Ichiro Okuhira; Sten Braesch-Andersen; Alan T Remaley
Journal:  FEBS Lett       Date:  2020-10-20       Impact factor: 4.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.